Skip to main content
Top
Published in: Acta Diabetologica 8/2017

01-08-2017 | Short Communication

Psoriasis in children with type 1 diabetes: A new comorbidity to be considered?

Authors: Luisa Di Costanzo, Valentina Fattorusso, Enza Mozzillo, Angela Patrì, Roberta Di Caprio, Elena De Nitto, Nicola Balato, Adriana Franzese

Published in: Acta Diabetologica | Issue 8/2017

Login to get access

Excerpt

Type 1 diabetes mellitus (T1DM) is the most common endocrine disease of childhood, due to an immune-mediated destruction of insulin-producing pancreatic β-cells. Comorbidities are frequent in T1DM and can severely affect clinical management [1]. To date, vitiligo and alopecia areata are the only described cutaneous comorbidities associated with T1DM, while psoriasis is usually associated with type 2 diabetes mellitus [2]. Psoriasis is an inflammatory skin disease affecting up to 2% of children in Europe and, in particular, 2.1% in Italy [3, 4]. To date, psoriasis prevalence in T1DM is not well known. …
Literature
3.
go back to reference Burden-The E, Thomas KS, Ratib S, Grindlay D, Adaji E, Murphy R (2016) The epidemiology of childhood psoriasis: a scoping review. Br J Dermatol 174(6):1242–1257. doi:10.1111/bjd.14507 CrossRef Burden-The E, Thomas KS, Ratib S, Grindlay D, Adaji E, Murphy R (2016) The epidemiology of childhood psoriasis: a scoping review. Br J Dermatol 174(6):1242–1257. doi:10.​1111/​bjd.​14507 CrossRef
4.
go back to reference Balato A, Di Costanzo L, Patruno C, Ayala F, Megna M, Balato N (2013) Psoriasis or psoriases. G Ital Dermatol Venereol 148:649–650PubMed Balato A, Di Costanzo L, Patruno C, Ayala F, Megna M, Balato N (2013) Psoriasis or psoriases. G Ital Dermatol Venereol 148:649–650PubMed
Metadata
Title
Psoriasis in children with type 1 diabetes: A new comorbidity to be considered?
Authors
Luisa Di Costanzo
Valentina Fattorusso
Enza Mozzillo
Angela Patrì
Roberta Di Caprio
Elena De Nitto
Nicola Balato
Adriana Franzese
Publication date
01-08-2017
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 8/2017
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-017-1000-3

Other articles of this Issue 8/2017

Acta Diabetologica 8/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.